| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/23/2005 | WO2005056002A2 Use of inductors of the degradation pathway of gamma-butyrolactone for inactivating the homoserine lactone n-acyl signal of gram-negative pathogenic bacteria |
| 06/23/2005 | WO2005055925A2 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types |
| 06/23/2005 | WO2005055813A2 Interaction of nmda receptor with the protein tyrosine phosphatase step in psychotic disorders |
| 06/23/2005 | WO2005055812A2 Serum biomarkers for chagas disease |
| 06/23/2005 | WO2005055808A2 Compositions and methods to diagnose and treat lung cancer |
| 06/23/2005 | WO2005055807A2 Methods and compositions for autism risk assessment background |
| 06/23/2005 | WO2005055804A2 Methods and compositions for diagnosing epithelial cell cancer |
| 06/23/2005 | WO2005049787A9 Compositions and methods for in vitro sorting of molecular and cellular libraries |
| 06/23/2005 | WO2005045426A3 Gene expression profiling of hazardous compounds and corresponding database clustering algorithm |
| 06/23/2005 | WO2005045061A3 Hybridization-based fluorescence assay |
| 06/23/2005 | WO2005040829A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 17 (gpr17) |
| 06/23/2005 | WO2005040401A3 Diagnostics and therapeutics for diseases associated with mosaic serine protease (msp) |
| 06/23/2005 | WO2005039724A3 Reactive polyurethane-based polamers |
| 06/23/2005 | WO2005037996A3 In vitro development of tissues and organs |
| 06/23/2005 | WO2005031359A3 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep (rnpep) |
| 06/23/2005 | WO2005030947A3 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases |
| 06/23/2005 | WO2005023083A3 Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| 06/23/2005 | WO2005022153A3 Compositions and methods for screening using populations of surrogate antibodies which comprise aptamers |
| 06/23/2005 | WO2005021800A8 Detection and quantitation of nucleic acid molecules in biological samples |
| 06/23/2005 | WO2005018436A8 Methods for the diagnosis, prognosis and treatment of metabolic syndrome |
| 06/23/2005 | WO2005015205A3 Use of sap |
| 06/23/2005 | WO2005014796A3 Methods and compositions for seamless cloning of nucleic acid molecules |
| 06/23/2005 | WO2005012501A3 Free-solution dna sequencing |
| 06/23/2005 | WO2005007814A3 Genome mapping of functional dna elements and cellular proteins |
| 06/23/2005 | WO2005002505A3 Apolipoprotein c-1 induced apoptosis |
| 06/23/2005 | WO2004098521A3 Treatment and diagnostics of cancer |
| 06/23/2005 | WO2004090153A3 Polymerase inhibitor and method of using same |
| 06/23/2005 | WO2004084708A3 Finding usable portion of sigmoid curve |
| 06/23/2005 | WO2004081535A3 The establishment of proteome structure profile databases and their uses |
| 06/23/2005 | WO2004058986A3 Btl-ii nucleic acids, proteins, and antibodies |
| 06/23/2005 | WO2004053141A3 Methods for rapid forensic analysis of mitochondrial dna and characterization of mitochondrial dna heteroplasmy |
| 06/23/2005 | WO2004052184A3 Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| 06/23/2005 | WO2004027079A3 Nuclear factor of activated t cells receptor |
| 06/23/2005 | WO2004000999A3 Identification of a receptor controlling migration and metastasis of skin cancer cells |
| 06/23/2005 | WO2003102163A8 Methods of diagnosing and treating diabetes and insulin resistance |
| 06/23/2005 | WO2003056896A3 Use of cytokines secreted by dendritic cells |
| 06/23/2005 | US20050138687 Using viral cell-to-cell transfer as screening and diagnostic tool in identifying triple gene block 3 mutants; generating disease resistant plants |
| 06/23/2005 | US20050138679 Method of evaluating useful cattle |
| 06/23/2005 | US20050138676 Identification of genes involved in Alzheimer's disease using Drosophila melanogaster |
| 06/23/2005 | US20050138675 Using metallothionein, atrial natriuretic factor/peptide and/or heat shock transport protein expression in rodent animal model, after exposure to agent, as diagnostic indicator of cardiotoxic compounds |
| 06/23/2005 | US20050137805 Gene expression profiles that identify genetically elite ungulate mammals |
| 06/23/2005 | US20050137391 Process for the synthesis of oligomeric compounds |
| 06/23/2005 | US20050137390 Deprotecting nucleotides having phosphotriester or phosphorodithioate linkages and at least one cyanoethyl protecting group by reaction with an amine deprotecting agent; solid phase synthesis |
| 06/23/2005 | US20050137389 Heterogeneous mixture of labeled nucleic acid fragments for chromosome preferential marking; karyotyping; genotyping |
| 06/23/2005 | US20050137388 Real-time nucleic acid detection processes and compositions |
| 06/23/2005 | US20050137158 Methods for targeting RNA molecules |
| 06/23/2005 | US20050137137 Inhibitors of the Interaction between p53 and MDM2 |
| 06/23/2005 | US20050137131 UspA1 and UspA2 antigens of Moraxella catarrhalis |
| 06/23/2005 | US20050136685 Chips, and apparatus and method for reaction analysis |
| 06/23/2005 | US20050136550 Flow control of electrochemical-based assay devices |
| 06/23/2005 | US20050136549 Method and system for automatically determining diagnostic saliency of digital images |
| 06/23/2005 | US20050136534 Apparatus and method for dispensing fluid, semi-solid and solid samples |
| 06/23/2005 | US20050136533 Evaluating sample on microarray so as not to cause deviation of site positions during measurement; microarrays |
| 06/23/2005 | US20050136529 Laminated assay devices |
| 06/23/2005 | US20050136528 Cell manipulating device comprising multiwell plate, controller and pipette for use in monitoring cell motility and response to exogenous proteins and chemical moieties |
| 06/23/2005 | US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 06/23/2005 | US20050136514 Related to sodium/glucose cotransporter subfamily; drug screening; biochips; host cells |
| 06/23/2005 | US20050136511 GABA B receptors |
| 06/23/2005 | US20050136509 Apparatus which utilizes digtal image analysis and immunohistochemical staining as tool in classification, diagnosis and prognosis of cancer |
| 06/23/2005 | US20050136508 Method and apparatus for detecting and quantifying bacterial spores on a surface |
| 06/23/2005 | US20050136507 Apparatus for collection of airborne microorganisms and gaseous effluvia; pollution control; screening for biochemical, chemical and/or bioterrorist weapons |
| 06/23/2005 | US20050136506 electrooptical method for quantifying motility response of cells to external stimuli, wherein target cell population (formed as a function of said response) is subsequently optically differentiated by addition of optical differentiation solution |
| 06/23/2005 | US20050136505 Solution contains coenzymes for hydrogen-transferring enzymes (nicotinamide adenine dinucleotide/phosphate) for determining presence of reduced lactate, glutamate, ammonia, alcohol, glyceraldehyde-3-phosphate, glucose, or dehydrogenases |
| 06/23/2005 | US20050136504 Method of measurement of protease and thin membranes used for said method |
| 06/23/2005 | US20050136502 Treatment of disorders associated with elevated blood glucose or blood pressure |
| 06/23/2005 | US20050136498 Using pregnancy-associated plasma protein-A (PAPP-A) as diagnostic indicator of cardiovascular and atherosclerotic disorders |
| 06/23/2005 | US20050136497 Assay buffer, compositions containing the same, and methods of using the same |
| 06/23/2005 | US20050136493 Using immunoglobulin to detect alpha -methylacyl-CoA racemase (AMACR) in urine; immunodiagnostic and cell proliferative disorders |
| 06/23/2005 | US20050136492 Such as caspases and serine proteases, for determining apoptotic state of a cell, detecting presence of tumor (cancer) cells, predicting efficacy of chemotherapy, and determining the probability of graft rejection or acceptance |
| 06/23/2005 | US20050136491 Method of site specific labeling of proteins and uses therefor |
| 06/23/2005 | US20050136478 Preparing microarray comprising cell surface ligands for use as to in separation and classification of cell types |
| 06/23/2005 | US20050136477 Elution with quaternary onium containing compound; lysis free; one-step; kits |
| 06/23/2005 | US20050136476 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 06/23/2005 | US20050136475 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/23/2005 | US20050136474 Truncation SELEX method |
| 06/23/2005 | US20050136470 Apparatus for detecting biopolymers and cartridge |
| 06/23/2005 | US20050136469 Photon reducing agents for fluorescence assays |
| 06/23/2005 | US20050136468 Methods to diagnose a required regulation of trophoblast invasion |
| 06/23/2005 | US20050136466 Use of electroactive indicator, an ionically labeled probe will attach to a complementary DNA segment, and a polymerase enzyme will release the ionic label; detecting the change in conductivity by measuring a change in the impedance been the two electrodes |
| 06/23/2005 | US20050136465 Screening assays |
| 06/23/2005 | US20050136464 Quantitation of biomolecule in a complex mixture by serial combinatorial dilution |
| 06/23/2005 | US20050136463 Recovering preferential nucleotide sequences from salt solution using alumina binding and centrifugation; solid phase extraction |
| 06/23/2005 | US20050136461 Human megakaryocyte-associated tyrosine kinase (MATK)-related gene variant associated with lung cancers |
| 06/23/2005 | US20050136460 Using expression pattern of multiple antibiotic resistance gene as an evaluative tool for monitoring efficacy of microbiocides |
| 06/23/2005 | US20050136459 Double adhesive covering comprised of hydrophobic material for use as sealing component in bipolymer array reaction chamber |
| 06/23/2005 | US20050136458 Method for nucleic acid preparation |
| 06/23/2005 | US20050136457 Using sequence specific searches of genome databases to screen for predicted genetic sites and/or chromosomal structures; bioinformatics |
| 06/23/2005 | US20050136455 Using elevated c-reactive protein concentration as diagnostic/prognostic indiactor of diabetes and/or coronary artery disease |
| 06/23/2005 | US20050136454 Cell-signaling assays |
| 06/23/2005 | US20050136453 Nucleic acid based nano-robotic system |
| 06/23/2005 | US20050136452 Methods for monitoring expression of polymorphic alleles |
| 06/23/2005 | US20050136451 Hypoxia responsive human CNGH 0002 genes and polypeptides |
| 06/23/2005 | US20050136450 Preparing drug model for treatments which target nervous system disorders; rational drug design |
| 06/23/2005 | US20050136449 For polypeptides having polyhistidine/polycysteine tags; cell extracts comprising nuclease inhibitors; kits |
| 06/23/2005 | US20050136448 Apparatus and methods for fluorescent detection of nucleic acids |
| 06/23/2005 | US20050136446 Method for the identification of microorganisms by means of in situ hybridization and flow cytometry |
| 06/23/2005 | US20050136445 Recombinant DNA vector, recombinant bio-luminescent bacterium and method for detecting bio-inhibitory substances using same |
| 06/23/2005 | US20050136443 Using cyclic replication to propagate and recover preferential nucleotide sequences; polymerase chain reaction |
| 06/23/2005 | US20050136442 Three dimensional apparatus and method for integrating sample preparation and multiplex assays |
| 06/23/2005 | US20050136441 Using strand displacement amplification to identify preferential nucleotides in solution; drug discovery; , pharmacogenomics; food and/or water monitoring and analysis |